Innerspace

Innerspace is a technology provider serving pharmaceutical manufacturers that operate aseptic production processes. Its core technology, branded Frame-by-Frame, decodes human and machine interaction into structured data and organizes process knowledge into a Digital Process Model. That model is intended to serve as a single data source supporting risk-based decision-making, consistent process documentation and operator training across the aseptic manufacturing lifecycle.

The company packages this technology into modular digital solutions addressing several use cases: training of aseptic behavior through immersive virtual reality simulation, technology transfer and harmonization of process knowledge across manufacturing sites, and structured setup of manufacturing equipment linking process design, risk management and training. The solutions are positioned for both large-scale fill-finish operations and cell and gene therapy environments. Company materials frame the value proposition around quality, compliance-relevant documentation and manufacturing efficiency, citing a 2025 European Court of Auditors report attributing 51% of medicine shortage root causes in the EEA to manufacturing issues.

Business model

Innerspace sells digital solutions and training programs to pharmaceutical manufacturers, delivered as modular offerings across the aseptic manufacturing lifecycle, including a virtual reality training simulator that can be integrated into a customer's existing training program. It also designs and delivers training content in partnership with an industry association.

Traction

Public references include the PDA partnership announced in June 2023, deployment of the VR Simulator at customer sites, use by pharmaceutical companies such as Fresenius Kabi and Ferring, and a consultant statement describing a collaboration that began roughly five years prior.

Latest developments

Company materials reference a 2025 European Court of Auditors special report on critical medicine shortages and describe an expanded solution portfolio spanning operator training, tech transfer and manufacturing equipment setup for both fill-finish and cell and gene therapy environments.